Aruna Kamineni, PhD, MPH
“I'm working on reducing cancer through better screening. I collaborate with researchers nationwide on studies that will make screening more effective, patient-friendly, and personalized.”
Aruna Kamineni, PhD, MPH
Assistant Investigator, Kaiser Permanente Washington Health Research Institute
Aruna.S.Kamineni@kp.org
206-287-2922
Biography
Aruna Kamineni, PhD, MPH, came to Kaiser Permanente Washington Health Research Institute in 2009 with a wealth of experience in chronic disease epidemiology. Dr. Kamineni has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.
Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.
Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.
Research interests and experience
-
Cancer
Cervical cancer; colorectal cancer; screening; disparities
-
Methods
Electronic clinical and administrative data infrastructure development for research; case-control studies; team science
-
Preventive Medicine
-
Women's Health
-
Cardiovascular Health
-
Chronic Illness Management
Recent publications
Owens CL, Peterson D, Kamineni A, Buist DS, Weinmann S, Ross TR, Williams AE, Stark A, Adams KF, Field TS. Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: Results from a multicenter US study. Cancer Cytopathol. 2013 Oct;121(10):568-75. doi:10.1002/cncy.21309. Epub 2013 May 8. PubMed
Rustagi AS, Kamineni A, Weiss NS. Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women. Am J Epidemiol. 2013 Oct 1;178(7):1020-2. doi: 10.1093/aje/kwt167. Epub 2013 Aug 21. PubMed
Kamineni A, Weinmann S, Shy KK, Glass AG, Weiss NS. Efficacy of screening in preventing cervical cancer among older women. Cancer Causes Control. 2013 Sep;24(9):1653-60. doi: 10.1007/s10552-013-0239-4. Epub 2013 Jun 7. PubMed
Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS. Measurement in comparative effectiveness research. Am J Prev Med. 2013 May;44(5):513-9. doi: 10.1016/j.amepre.2013.01.006. PubMed
Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158(5 Pt 1):312-20. doi: 10.7326/0003-4819-158-5-201303050-00003. PubMed
Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes Control. 2013 Feb;24(2):305-12. doi: 10.1007/s10552-012-0115-7. Epub 2012 Dec 7. PubMed
Kamineni A, Halgrim S, Gundersen G, Fuller S, Hart G, Carrell D, Rutter C. PS2-26: Coordinating heterogeneous data and mixed collection methods to support population-based cancer screening research. Clin Med Res. 2013;11(3):154. PubMed
Zieman SJ, Kamineni A, Ix JH, Barzilay J, Djousse L, Kizer JR, Biggs ML, de Boer IH, Chonchol M, Gottdiener JS, Selvin E, Newman AB, Kuller LH, Siscovick DS, Mukamal KJ. Hemoglobin A1c and arterial and ventricular stiffness in older adults. PLoS One. 2012;7(10):e47941. doi: 10.1371/journal.pone.0047941. Epub 2012 Oct 30. PubMed
Buist D, Tuzzio L, Greenlee R, Field T, Williams A, Weinmann S, Stout N, Kamineni A, Doubeni C. Cancer screening guideline development, implementation and dissemination: connection points for researchers and health care delivery systems for comparative effectiveness research. Clin Med Res. 2012;10(3):157. PubMed
Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP. Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6. Epub 2011 Aug 30. PubMed
Research
Improving cancer prevention and early detection
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Healthy findings blog
Improving reporting of cancer screening harms
Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.
innovating care
How to maximize screening for colon cancer
Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.
KPWHRI in the Media
Aruna Kamineni, PhD, MPH, comments on new study of cancer screening guidelines
NCI study analyzes the harms from cancer screening
Managed Healthcare Executive, Dec. 8, 2022
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.